Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SUNNYVALE, Calif., May 22, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via webcast.
Jefferies Global Healthcare Conference, New York, NY
Monday, June 2, 2014 at 11.00 a.m. Eastern Time
William Blair Growth Stock Conference, Chicago, IL
Wednesday, June 11, 2014 at 8.00 a.m. Central Time
Goldman Sachs Global Healthcare Conference, Rancho Palos Verdes, CA
Thursday, June 12, 2014 at 9.20 a.m. Pacific Time
JMP Securities Healthcare Conference, New York, NY
Wednesday, June 25, 2014 at 12.00 p.m. Eastern Time
Accessing Live Webcasts
To access the live webcasts for these events, please visit Cepheid's website at http://ir.cepheid.com at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. A replay of the webcasts will be available shortly following the presentation and will remain available for at least 90 days.
Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com.
For Media Inquiries:
For Investor Inquiries:
Cepheid Corporate Communications
Tel: (408) 400-8377
Cepheid Investor Relations
Tel: (408) 400-8329
©2012 PR Newswire. All Rights Reserved.